Molecular Landscape with Human Liver Cancer Global Gene Profiling of Spontaneous Hepatocellular Carcinoma in B 6 C 3 F 1 Mice : Similarities in the
暂无分享,去创建一个
Scott | Š. | D. | R. | J. | Robert | Stéphanie | Á. | Mark | K. Gerrish | Sills | Shyamal | T. Masinde | Auerbach | C. | Keith | Hu | Arun | Pandiri | Hoenerhoff | Lahousse | Hua Hong | Shockley | Peddada | J.
[1] K. Tomer,et al. Gene Expression and Mutation Assessment Provide Clues of Genetic and Epigenetic Mechanisms in Liver Tumors of Oxazepam-Exposed Mice , 2011, Veterinary pathology.
[2] M. Ronaghi,et al. Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data , 2010, PloS one.
[3] Wenge Guo,et al. Controlling False Discoveries in Multidimensional Directional Decisions, with Applications to Gene Expression Data on Ordered Categories , 2010, Biometrics.
[4] G. Cabibbo,et al. Epidemiology, risk factors and surveillance of hepatocellular carcinoma. , 2010, European review for medical and pharmacological sciences.
[5] H. Papadaki,et al. Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin. , 2010, Histology and histopathology.
[6] Donald Wlodkowic,et al. Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy. , 2009, European journal of pharmacology.
[7] F. Heindryckx,et al. Experimental mouse models for hepatocellular carcinoma research , 2009, International journal of experimental pathology.
[8] Jan-Gowth Chang,et al. Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications , 2009, Journal of Cancer Research and Clinical Oncology.
[9] Goberdhan P Dimri,et al. BMI1 Cooperates with H-RAS to Induce an Aggressive Breast Cancer Phenotype with Brain Metastases , 2009, Oncogene.
[10] R. Floyd,et al. In vivo MRS assessment of altered fatty acyl unsaturation in liver tumor formation of a TGF alpha/c-myc transgenic mouse model. , 2009, Journal of lipid research.
[11] S. Thorgeirsson,et al. Central role of c-Myc during malignant conversion in human hepatocarcinogenesis. , 2009, Cancer research.
[12] S. Altekruse,et al. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] R. Maronpot. Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains , 2009, Journal of toxicologic pathology.
[14] K. Cooper,et al. Glypican-3: A Novel Diagnostic Marker for Hepatocellular Carcinoma and More , 2009, Advances in anatomic pathology.
[15] T. Mok,et al. New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Shu-Hui Zhang,et al. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma. , 2008, Human pathology.
[17] V. Herlea,et al. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma. , 2008, Journal of gastrointestinal and liver diseases : JGLD.
[18] L. Michel,et al. c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1. , 2008, World journal of gastroenterology.
[19] Jorng-Tzong Horng,et al. Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma , 2008, Oncogene.
[20] S. Thibodeau,et al. The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. , 2008, Journal of hepatology.
[21] A. Jacobsson,et al. Steroid hormones control circadian ELOVL3 expression in mouse liver , 2008 .
[22] Hongmin Li,et al. A Precisely Regulated Gene Expression Cassette Potently Modulates Metastasis and Survival in Multiple Solid Cancers , 2008, PLoS Genetics.
[23] S. Thorgeirsson,et al. Transforming growth factor‐β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer , 2008, Hepatology.
[24] Y. Takeda,et al. Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data. , 2008, European journal of cancer.
[25] I. Tischoff,et al. DNA methylation in hepatocellular carcinoma. , 2008, World journal of gastroenterology.
[26] Y. Matsuda. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. , 2008, World journal of gastroenterology.
[27] A. Buchmann,et al. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis. , 2008, Mutation research.
[28] R. Fry,et al. Hepatocellular carcinoma associated with liver-gender disruption in male mice. , 2007, Cancer research.
[29] Ji-Shin Lee,et al. Genetic alterations of Wnt signaling pathway–associated genes in hepatocellular carcinoma , 2007, Journal of gastroenterology and hepatology.
[30] Sheng-Nan Lu,et al. Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection. , 2007, Oncology reports.
[31] C. Fan,et al. The Role of Gas1 in Embryonic Development and its Implications for Human Disease , 2007, Cell cycle.
[32] Goberdhan P Dimri,et al. Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. , 2007, Cancer research.
[33] Cristel G. Thomas,et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry , 2007, Hepatology.
[34] H. El‐Serag,et al. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.
[35] J. Yun,et al. Identification and characterization of BH3 domain protein Bim and its isoforms in human hepatocellular carcinomas , 2007, Apoptosis.
[36] Yong Zhang,et al. Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[37] O. Mariani,et al. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. , 2007, Cancer cell.
[38] C. Harris,et al. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer , 2007, Oncogene.
[39] V. Mazzaferro,et al. Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.
[40] Stéphane Larochelle,et al. Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. , 2007, Molecular cell.
[41] S. Cheung,et al. Atypical localization of membrane type 1‐matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma , 2007, Molecular carcinogenesis.
[42] Jie-quan Yang,et al. Elevated Expression of Autocrine Motility Factor Receptor Correlates with Overexpression of RhoC and Indicates Poor Prognosis in Hepatocellular Carcinoma , 2007, Digestive Diseases and Sciences.
[43] K. Arai,et al. Phosphorylation of MCM4 by Cdc7 Kinase Facilitates Its Interaction with Cdc45 on the Chromatin*♦ , 2006, Journal of Biological Chemistry.
[44] V. Paradis,et al. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. , 2006, Human pathology.
[45] M. Schwarz,et al. Rex3 (reduced in expression 3) as a new tumor marker in mouse hepatocarcinogenesis. , 2006, Toxicology.
[46] G. Sumara,et al. c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. , 2006, Genes & development.
[47] P. Pineau,et al. Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma , 2006, Molecular and Cellular Endocrinology.
[48] V. Radha,et al. Involvement of caspase 1 and its activator Ipaf upstream of mitochondrial events in apoptosis , 2006, The FEBS journal.
[49] Xiaohong Wu,et al. Differences in cytochrome P450 2C19 (CYP2C19) expression in adjacent normal and tumor tissues in Chinese cancer patients. , 2006, Medical science monitor : international medical journal of experimental and clinical research.
[50] Fumio Hanaoka,et al. Site‐specific phosphorylation of MCM4 during the cell cycle in mammalian cells , 2006, The FEBS journal.
[51] Q. Hong,et al. WOX1 Is Essential for Tumor Necrosis Factor-, UV Light-, Staurosporine-, and p53-mediated Cell Death, and Its Tyrosine 33-phosphorylated Form Binds and Stabilizes Serine 46-phosphorylated p53* , 2005, Journal of Biological Chemistry.
[52] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[53] M. Miyazaki,et al. Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[54] C. Lobe,et al. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. , 2005, Cancer research.
[55] Hiroki Nagase,et al. Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma , 2005, International journal of gastrointestinal cancer.
[56] B. Rozell,et al. Human sterol 12α-hydroxylase (CYP8B1) is mainly expressed in hepatocytes in a homogenous pattern , 2005, Histochemistry and Cell Biology.
[57] J. Squire,et al. Karyotypic imbalances and differential gene expressions in the acquired doxorubicin resistance of hepatocellular carcinoma cells , 2005, Laboratory Investigation.
[58] M. Makuuchi,et al. Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas. , 2005, International journal of oncology.
[59] O. Musso,et al. Upregulation of DNA repair genes in active cirrhosis associated with hepatocellular carcinoma , 2005, FEBS letters.
[60] S. Thorgeirsson,et al. Molecular Mechanisms of Hepatocarcinogenesis in Transgenic Mouse Models of Liver Cancer , 2005, Toxicologic pathology.
[61] Christopher H. Contag,et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer , 2004, Nature.
[62] Joo Heon Kim,et al. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. , 2004, Breast.
[63] J. Fox,et al. Progression of Chronic Hepatitis and Preneoplasia in Helicobacter hepaticus-Infected A/JCr Mice , 2004, Toxicologic pathology.
[64] J. Thacker,et al. The XRCC genes: expanding roles in DNA double-strand break repair. , 2004, DNA repair.
[65] J. Ludes-Meyers,et al. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma , 2004, British Journal of Cancer.
[66] T. Kudo,et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death , 2004, The Journal of cell biology.
[67] Philip M. Long,et al. Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach , 2004, Hepatology.
[68] B. Mellström,et al. Glial-specific retrovirally mediated gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo , 2004, Neurobiology of Disease.
[69] M. Lohuizen,et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas , 2004, Nature.
[70] D. Harrison,et al. The JAK/STAT signaling pathway , 2004, Journal of Cell Science.
[71] Mengsen Li,et al. Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells. , 2004, World journal of gastroenterology.
[72] Chiao-Ying Lin,et al. Overexpression and Amplification of Aurora-A in Hepatocellular Carcinoma , 2004, Clinical Cancer Research.
[73] R. Xu,et al. An update on the molecular genetics of hepatocellular carcinoma. , 2004, Seminars in liver disease.
[74] H. Zhang,et al. Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.
[75] S. Hirohashi,et al. Possible involvement of tetraspanin CO‐029 in hematogenous intrahepatic metastasis of liver cancer cells , 2003, Journal of gastroenterology and hepatology.
[76] Wei Wang,et al. Expression and significance of RhoC gene in hepatocellular carcinoma. , 2003, World journal of gastroenterology.
[77] D. Tenen,et al. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPα DNA binding via leucine zipper domain interaction , 2003, Oncogene.
[78] T. Devereux,et al. Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. , 2003, Toxicology and applied pharmacology.
[79] Wen Shi,et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. , 2003, Gastroenterology.
[80] Hans Clevers,et al. Caught up in a Wnt storm: Wnt signaling in cancer. , 2003, Biochimica et biophysica acta.
[81] Stephen C. West,et al. Molecular views of recombination proteins and their control , 2003, Nature Reviews Molecular Cell Biology.
[82] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[83] E. Wagner,et al. Liver Tumor Development c-Jun Antagonizes the Proapoptotic Activity of p53 , 2003, Cell.
[84] Jian-hua Xu,et al. Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma. , 2002, World journal of gastroenterology.
[85] Wei-Min Liu,et al. Robust estimators for expression analysis , 2002, Bioinform..
[86] Judith Campisi,et al. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. , 2002, Cancer research.
[87] H. Stein,et al. Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB , 2002, The EMBO journal.
[88] S. Thorgeirsson,et al. Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.
[89] Tatjana Crnogorac-Jurcevic,et al. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. , 2002, The American journal of pathology.
[90] E. Wagner,et al. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c‐jun in the liver , 2002, The EMBO journal.
[91] D. Zimonjic,et al. Chromosome‐mediated alterations of the MYC gene in human cancer , 2002, Journal of cellular and molecular medicine.
[92] Y. Morishita,et al. Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma. . , 2002, Anticancer research.
[93] C Eng,et al. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[94] S. Hirohashi,et al. Overexpression of tetraspanin CO-029 in hepatocellular carcinoma. , 2001, Journal of hepatology.
[95] S. Thibodeau,et al. hMLH1 and hMSH2 expression in human hepatocellular carcinoma. , 2001, International journal of oncology.
[96] D. Parkin,et al. Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.
[97] M. Lohuizen,et al. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression , 2001, British Journal of Cancer.
[98] Y. Tan,et al. Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance. , 2001, World journal of gastroenterology.
[99] S. Rane,et al. Janus kinases: components of multiple signaling pathways , 2000, Oncogene.
[100] M. Buendia. Genetics of hepatocellular carcinoma. , 2000, Seminars in cancer biology.
[101] D. Graham,et al. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. , 2000, The American journal of pathology.
[102] B. Rayet,et al. Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.
[103] B. le Bail,et al. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma , 1999, The Journal of pathology.
[104] R. Dalla‐Favera,et al. Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.
[105] R. Poulsom,et al. Primary mucinous carcinomas of the skin express TFF1, TFF3, estrogen receptor, and progesterone receptors. , 1998, The American journal of surgical pathology.
[106] M. Buendia,et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[107] W. Bodmer,et al. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[108] A. Evdokiou,et al. Tumor‐suppressive activity of the growth arrest‐specific gene GAS1 in human tumor cell lines , 1998, International journal of cancer.
[109] A. Hochberg,et al. Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. , 1998, Molecular pathology : MP.
[110] S. Hirohashi,et al. E‐cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma , 1996, Hepatology.
[111] J. Ward,et al. Emerging Issues in Mouse Liver Carcinogenesis , 1996, Toxicologic pathology.
[112] V. Castronovo,et al. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. , 1995, Oncogene.
[113] J. Roth,et al. Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma. , 1995, Oncogene.
[114] R. Maronpot,et al. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. , 1995, Toxicology.
[115] R. Levine,et al. Carbonic Anhydrase III. OXIDATIVE MODIFICATION IN VIVO AND LOSS OF PHOSPHATASE ACTIVITY DURING AGING (*) , 1995, The Journal of Biological Chemistry.
[116] J M Ward,et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. , 1994, Journal of the National Cancer Institute.
[117] S. Hirohashi,et al. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. , 1994, Cancer research.
[118] V. Castronovo,et al. The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines. , 1994, Biochemical pharmacology.
[119] Y. Haupt,et al. bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. , 1993, Oncogene.
[120] H. Hsu,et al. Amplification of the c-myc gene in human hepatocellular carcinoma: biologic significance. , 1993, Journal of the Formosan Medical Association = Taiwan yi zhi.
[121] A. Nonomura,et al. Alpha‐fetoprotein production by hepatocellular carcinoma is prognostic of poor patients survival , 1992, Journal of surgical oncology.
[122] W. Alexander,et al. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice , 1991, Cell.
[123] E. Farber. Pathogenesis of liver cancer. , 1974, Archives of pathology.
[124] M. Zöller. Tetraspanins: push and pull in suppressing and promoting metastasis , 2009, Nature Reviews Cancer.
[125] Jing Zhao,et al. Wnt/beta-catenin signaling pathway may regulate cell cycle and expression of cyclin A and cyclin E protein in hepatocellular carcinoma cells. , 2009, Cell cycle.
[126] 谷口 哲郎. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32 , 2008 .
[127] H. Huber,et al. PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. , 2007, Oncogene.
[128] J. Abecassis,et al. Cisplatin-induced genes as potential markers for thyroid cancer , 2004, Cellular and Molecular Life Sciences CMLS.
[129] M. Yuen,et al. Expression of c‐Myc, c‐Fos, and c‐Jun in hepatocellular carcinoma , 2001, Cancer.
[130] R. Ge,et al. Effect of trichloroethylene on DNA methylation and expression of early‐intermediate protooncogenes in the liver of B6C3F1 mice , 1999, Journal of biochemical and molecular toxicology.
[131] F. May,et al. Trefoil proteins: their role in normal and malignant cells. , 1997, The Journal of pathology.
[132] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[133] S. Thorgeirsson,et al. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. , 1993, Cancer research.